HKPX3
MCID: HYP519
MIFTS: 18

Hyperekplexia 3 (HKPX3)

Categories: Genetic diseases, Metabolic diseases, Neuronal diseases, Rare diseases, Respiratory diseases

Aliases & Classifications for Hyperekplexia 3

MalaCards integrated aliases for Hyperekplexia 3:

Name: Hyperekplexia 3 58 12 76 30 13 6 74
Hkpx3 58 12 76
Hyperekplexia, Type 3 41

Characteristics:

OMIM:

58
Inheritance:
autosomal recessive
autosomal dominant

Miscellaneous:
onset in infancy
some patients have resolution of symptoms in first year of life


HPO:

33
hyperekplexia 3:
Onset and clinical course infantile onset
Inheritance autosomal recessive inheritance autosomal dominant inheritance


Classifications:



External Ids:

Disease Ontology 12 DOID:0060698
OMIM 58 614618
MeSH 45 D000071017
ICD10 34 G25.8
UMLS 74 C3553288

Summaries for Hyperekplexia 3

UniProtKB/Swiss-Prot : 76 Hyperekplexia 3: A neurologic disorder characterized by neonatal hypertonia, an exaggerated startle response to tactile or acoustic stimuli, and life- threatening neonatal apnea episodes. Notably, in some cases, symptoms resolved in the first year of life.

MalaCards based summary : Hyperekplexia 3, is also known as hkpx3, and has symptoms including muscular stiffness An important gene associated with Hyperekplexia 3 is SLC6A5 (Solute Carrier Family 6 Member 5). Related phenotypes are hypertonia and apnea

Disease Ontology : 12 A hyperekplexia that has material basis in homozygous or compound heterozygous mutation in the SLC6A5 gene on chromosome 11p15.

Description from OMIM: 614618

Related Diseases for Hyperekplexia 3

Symptoms & Phenotypes for Hyperekplexia 3

Human phenotypes related to Hyperekplexia 3:

33
# Description HPO Frequency HPO Source Accession
1 hypertonia 33 HP:0001276
2 apnea 33 HP:0002104
3 muscle stiffness 33 HP:0003552
4 exaggerated startle response 33 HP:0002267

Symptoms via clinical synopsis from OMIM:

58
Muscle Soft Tissue:
muscle stiffness
hypertonia, neonatal

Respiratory:
apneic episodes, neonatal
breath-holding episodes, infancy

Neurologic Central Nervous System:
hypertonicity
exaggerated startle response to tactile or acoustic stimuli

Clinical features from OMIM:

614618

UMLS symptoms related to Hyperekplexia 3:


muscular stiffness

Drugs & Therapeutics for Hyperekplexia 3

Search Clinical Trials , NIH Clinical Center for Hyperekplexia 3

Genetic Tests for Hyperekplexia 3

Genetic tests related to Hyperekplexia 3:

# Genetic test Affiliating Genes
1 Hyperekplexia 3 30 SLC6A5

Anatomical Context for Hyperekplexia 3

Publications for Hyperekplexia 3

Variations for Hyperekplexia 3

UniProtKB/Swiss-Prot genetic disease variations for Hyperekplexia 3:

76
# Symbol AA change Variation ID SNP ID
1 SLC6A5 p.Leu306Val VAR_044168 rs121908496
2 SLC6A5 p.Thr425Met VAR_044169 rs121908498
3 SLC6A5 p.Trp482Cys VAR_044171
4 SLC6A5 p.Tyr491Cys VAR_044172 rs121908494
5 SLC6A5 p.Asn509Ser VAR_044174 rs121908497
6 SLC6A5 p.Ser510Arg VAR_044175 rs281864926

ClinVar genetic disease variations for Hyperekplexia 3:

6 (show all 44)
# Gene Variation Type Significance SNP ID Assembly Location
1 SLC6A5 NM_004211.4(SLC6A5): c.1131C> A (p.Tyr377Ter) single nucleotide variant Pathogenic rs121908493 GRCh37 Chromosome 11, 20639301: 20639301
2 SLC6A5 NM_004211.4(SLC6A5): c.1131C> A (p.Tyr377Ter) single nucleotide variant Pathogenic rs121908493 GRCh38 Chromosome 11, 20617755: 20617755
3 SLC6A5 NM_004211.4(SLC6A5): c.1294delGinsTT (p.Val432Phefs) indel Pathogenic rs281864924 GRCh37 Chromosome 11, 20648287: 20648287
4 SLC6A5 NM_004211.4(SLC6A5): c.1294delGinsTT (p.Val432Phefs) indel Pathogenic rs281864924 GRCh38 Chromosome 11, 20626741: 20626741
5 SLC6A5 NM_004211.4(SLC6A5): c.1472A> G (p.Tyr491Cys) single nucleotide variant Pathogenic rs121908494 GRCh37 Chromosome 11, 20649602: 20649602
6 SLC6A5 NM_004211.4(SLC6A5): c.1472A> G (p.Tyr491Cys) single nucleotide variant Pathogenic rs121908494 GRCh38 Chromosome 11, 20628056: 20628056
7 SLC6A5 NM_004211.4(SLC6A5): c.1888C> T (p.Gln630Ter) single nucleotide variant Pathogenic rs121908495 GRCh37 Chromosome 11, 20660023: 20660023
8 SLC6A5 NM_004211.4(SLC6A5): c.1888C> T (p.Gln630Ter) single nucleotide variant Pathogenic rs121908495 GRCh38 Chromosome 11, 20638477: 20638477
9 SLC6A5 NM_004211.4(SLC6A5): c.916C> G (p.Leu306Val) single nucleotide variant Pathogenic rs121908496 GRCh37 Chromosome 11, 20629129: 20629129
10 SLC6A5 NM_004211.4(SLC6A5): c.916C> G (p.Leu306Val) single nucleotide variant Pathogenic rs121908496 GRCh38 Chromosome 11, 20607583: 20607583
11 SLC6A5 NM_004211.4(SLC6A5): c.1526A> G (p.Asn509Ser) single nucleotide variant Pathogenic rs121908497 GRCh37 Chromosome 11, 20652263: 20652263
12 SLC6A5 NM_004211.4(SLC6A5): c.1526A> G (p.Asn509Ser) single nucleotide variant Pathogenic rs121908497 GRCh38 Chromosome 11, 20630717: 20630717
13 SLC6A5 NM_004211.4(SLC6A5): c.1274C> T (p.Thr425Met) single nucleotide variant Pathogenic rs121908498 GRCh37 Chromosome 11, 20648267: 20648267
14 SLC6A5 NM_004211.4(SLC6A5): c.1274C> T (p.Thr425Met) single nucleotide variant Pathogenic rs121908498 GRCh38 Chromosome 11, 20626721: 20626721
15 SLC6A5 NM_004211.4(SLC6A5): c.1530T> G (p.Ser510Arg) single nucleotide variant Pathogenic rs281864926 GRCh37 Chromosome 11, 20652267: 20652267
16 SLC6A5 NM_004211.4(SLC6A5): c.1530T> G (p.Ser510Arg) single nucleotide variant Pathogenic rs281864926 GRCh38 Chromosome 11, 20630721: 20630721
17 SLC6A5 NM_004211.4(SLC6A5): c.1444T> C (p.Trp482Arg) single nucleotide variant Pathogenic rs281864925 GRCh37 Chromosome 11, 20649574: 20649574
18 SLC6A5 NM_004211.4(SLC6A5): c.1444T> C (p.Trp482Arg) single nucleotide variant Pathogenic rs281864925 GRCh38 Chromosome 11, 20628028: 20628028
19 SLC6A5 NM_004211.4(SLC6A5): c.323delC (p.Pro108Leufs) deletion Pathogenic rs281864923 GRCh37 Chromosome 11, 20622994: 20622994
20 SLC6A5 NM_004211.4(SLC6A5): c.323delC (p.Pro108Leufs) deletion Pathogenic rs281864923 GRCh38 Chromosome 11, 20601448: 20601448
21 SLC6A5 NM_004211.4(SLC6A5): c.266C> A (p.Ala89Glu) single nucleotide variant Benign/Likely benign rs61736602 GRCh38 Chromosome 11, 20601391: 20601391
22 SLC6A5 NM_004211.4(SLC6A5): c.266C> A (p.Ala89Glu) single nucleotide variant Benign/Likely benign rs61736602 GRCh37 Chromosome 11, 20622937: 20622937
23 SLC6A5 NM_004211.4(SLC6A5): c.342C> G (p.Pro114=) single nucleotide variant Benign/Likely benign rs61736605 GRCh38 Chromosome 11, 20601467: 20601467
24 SLC6A5 NM_004211.4(SLC6A5): c.342C> G (p.Pro114=) single nucleotide variant Benign/Likely benign rs61736605 GRCh37 Chromosome 11, 20623013: 20623013
25 SLC6A5 NM_004211.4(SLC6A5): c.2103G> A (p.Glu701=) single nucleotide variant Benign rs2276433 GRCh37 Chromosome 11, 20673867: 20673867
26 SLC6A5 NM_004211.4(SLC6A5): c.2103G> A (p.Glu701=) single nucleotide variant Benign rs2276433 GRCh38 Chromosome 11, 20652321: 20652321
27 SLC6A5 NM_004211.4(SLC6A5): c.395C> G (p.Ala132Gly) single nucleotide variant Benign rs34243519 GRCh38 Chromosome 11, 20601520: 20601520
28 SLC6A5 NM_004211.4(SLC6A5): c.395C> G (p.Ala132Gly) single nucleotide variant Benign rs34243519 GRCh37 Chromosome 11, 20623066: 20623066
29 SLC6A5 NM_004211.4(SLC6A5): c.500C> A (p.Thr167Lys) single nucleotide variant Benign rs61736603 GRCh38 Chromosome 11, 20601625: 20601625
30 SLC6A5 NM_004211.4(SLC6A5): c.500C> A (p.Thr167Lys) single nucleotide variant Benign rs61736603 GRCh37 Chromosome 11, 20623171: 20623171
31 SLC6A5 NM_004211.4(SLC6A5): c.683C> A (p.Ala228Asp) single nucleotide variant Uncertain significance rs371265931 GRCh38 Chromosome 11, 20607010: 20607010
32 SLC6A5 NM_004211.4(SLC6A5): c.683C> A (p.Ala228Asp) single nucleotide variant Uncertain significance rs371265931 GRCh37 Chromosome 11, 20628556: 20628556
33 SLC6A5 NM_004211.4(SLC6A5): c.1640T> C (p.Phe547Ser) single nucleotide variant Uncertain significance rs772652517 GRCh37 Chromosome 11, 20657868: 20657868
34 SLC6A5 NM_004211.4(SLC6A5): c.1640T> C (p.Phe547Ser) single nucleotide variant Uncertain significance rs772652517 GRCh38 Chromosome 11, 20636322: 20636322
35 SLC6A5 NM_004211.4(SLC6A5): c.811+3G> A single nucleotide variant Uncertain significance rs1555039131 GRCh38 Chromosome 11, 20607141: 20607141
36 SLC6A5 NM_004211.4(SLC6A5): c.811+3G> A single nucleotide variant Uncertain significance rs1555039131 GRCh37 Chromosome 11, 20628687: 20628687
37 SLC6A5 NM_004211.4(SLC6A5): c.1913C> T (p.Ser638Phe) single nucleotide variant Uncertain significance GRCh38 Chromosome 11, 20638502: 20638502
38 SLC6A5 NM_004211.4(SLC6A5): c.1913C> T (p.Ser638Phe) single nucleotide variant Uncertain significance GRCh37 Chromosome 11, 20660048: 20660048
39 SLC6A5 NM_004211.4(SLC6A5): c.1736T> C (p.Met579Thr) single nucleotide variant Uncertain significance GRCh38 Chromosome 11, 20636418: 20636418
40 SLC6A5 NM_004211.4(SLC6A5): c.1736T> C (p.Met579Thr) single nucleotide variant Uncertain significance GRCh37 Chromosome 11, 20657964: 20657964
41 SLC6A5 NM_004211.4(SLC6A5): c.2296C> T (p.Arg766Cys) single nucleotide variant Uncertain significance GRCh38 Chromosome 11, 20654770: 20654770
42 SLC6A5 NM_004211.4(SLC6A5): c.2296C> T (p.Arg766Cys) single nucleotide variant Uncertain significance GRCh37 Chromosome 11, 20676316: 20676316
43 SLC6A5 NM_004211.4(SLC6A5): c.571C> T (p.Arg191Ter) single nucleotide variant Pathogenic GRCh38 Chromosome 11, 20604316: 20604316
44 SLC6A5 NM_004211.4(SLC6A5): c.571C> T (p.Arg191Ter) single nucleotide variant Pathogenic GRCh37 Chromosome 11, 20625862: 20625862

Expression for Hyperekplexia 3

Search GEO for disease gene expression data for Hyperekplexia 3.

Pathways for Hyperekplexia 3

GO Terms for Hyperekplexia 3

Sources for Hyperekplexia 3

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....